PER
Click for more information
5.00% 8.4¢ percheron therapeutics limited

Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US

  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    01/06/21
    10:18
    Post #: 53555267
    Likes Created with Sketch. 35  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢ 		Change
0.004(5.00%) 		Mkt cap ! $75.72M
Open High Low Value Volume
8.0¢ 8.4¢ 8.0¢ $26.89K 328.0K

Buyers (Bids)

No. Vol. Price($)
1 9602 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 58051 1
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.